Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 58524-83-7
2. Rs-2386
3. 8y88cp83mk
4. [2-[(1s,2s,4r,8s,9s,11s,12r,13s,19s)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] Cyclopropanecarboxylate
5. Ciprocinonida
6. Ciprocinonidum
7. Rs 2386
8. Ciprocinonide [usan:inn]
9. Ciprocinonidum [inn-latin]
10. Unii-8y88cp83mk
11. Ciprocinonida [inn-spanish]
12. Einecs 261-307-5
13. Ciprocinonide [inn]
14. Ciprocinonide (usan/inn)
15. Ciprocinonide [usan]
16. Ciprocinonide [mart.]
17. Schembl122617
18. Ciprocinonide [who-dd]
19. Chembl2105934
20. Dtxsid601024166
21. Zinc4212545
22. 16alpha,17-dimethylmethylendioxy-6alpha,9-difluor-11beta,21-dihydroxy-1,4-pregnadien-3,20-dion-21-cyclopropancarboxylat
23. 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-acetal With Acetone, 21-cyclopropanecarboxylate
24. D03520
25. Q27271198
26. 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-acetal With Acetone, 21-cyclopropanecarboxylate
27. Pregna-1,4-diene-3,20-dione, 21-((cyclopropylcarbonyl)oxy)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6.alpha.,11.beta.,16.alpha.)-
28. Pregna-1,4-diene-3,20-dione, 21-((cyclopropylcarbonyl)oxy)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-
| Molecular Weight | 520.6 g/mol |
|---|---|
| Molecular Formula | C28H34F2O7 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 520.22725974 g/mol |
| Monoisotopic Mass | 520.22725974 g/mol |
| Topological Polar Surface Area | 99.1 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 1140 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Ciprocinonide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ciprocinonide, including repackagers and relabelers. The FDA regulates Ciprocinonide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ciprocinonide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ciprocinonide supplier is an individual or a company that provides Ciprocinonide active pharmaceutical ingredient (API) or Ciprocinonide finished formulations upon request. The Ciprocinonide suppliers may include Ciprocinonide API manufacturers, exporters, distributors and traders.
click here to find a list of Ciprocinonide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ciprocinonide DMF (Drug Master File) is a document detailing the whole manufacturing process of Ciprocinonide active pharmaceutical ingredient (API) in detail. Different forms of Ciprocinonide DMFs exist exist since differing nations have different regulations, such as Ciprocinonide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ciprocinonide DMF submitted to regulatory agencies in the US is known as a USDMF. Ciprocinonide USDMF includes data on Ciprocinonide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ciprocinonide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ciprocinonide suppliers with USDMF on PharmaCompass.
Ciprocinonide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ciprocinonide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ciprocinonide GMP manufacturer or Ciprocinonide GMP API supplier for your needs.
A Ciprocinonide CoA (Certificate of Analysis) is a formal document that attests to Ciprocinonide's compliance with Ciprocinonide specifications and serves as a tool for batch-level quality control.
Ciprocinonide CoA mostly includes findings from lab analyses of a specific batch. For each Ciprocinonide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ciprocinonide may be tested according to a variety of international standards, such as European Pharmacopoeia (Ciprocinonide EP), Ciprocinonide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ciprocinonide USP).
LOOKING FOR A SUPPLIER?
